Related Experiment Video

Updated: Sep 23, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases

Pascal Peschard1, Morag Park

  • 1Department of Biochemistry, McGill University, Molecular Oncology Group, McGill University Health Centre, Montréal, Québec, Canada, H3A 1A1.

Cancer Cell
|July 5, 2003
PubMed

Insights

Loss of receptor ubiquitination disrupts normal cell surface receptor removal, contributing to cancer development. Understanding these molecular changes is key to targeting growth factor receptor tyrosine kinases (RTKs) in cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Growth factor receptor tyrosine kinases (RTKs) are frequently deregulated in cancers, often due to enhanced signaling.
  • Negative regulatory mechanisms are crucial for controlling RTK activity and preventing oncogenesis.
  • RTK downregulation typically involves endocytosis and lysosomal degradation, processes linked to receptor ubiquitination.

Purpose of the Study:

  • To review molecular mechanisms underlying RTK deregulation in cancer.
  • To highlight the role of impaired ubiquitination in RTK pathogenesis.
  • To explore how loss of ubiquitination contributes to cancer development.

Main Methods:

  • Literature review of molecular alterations affecting RTK regulation.
  • Analysis of the link between RTK endocytosis, lysosomal targeting, and ubiquitination.
  • Examination of evidence implicating impaired ubiquitination in cancer pathogenesis.

Main Results:

  • Deregulation of RTKs is a common feature in many malignancies.
  • Loss of negative regulatory pathways, particularly ubiquitination, is a significant factor in RTK deregulation.
  • Impaired ubiquitination can lead to sustained RTK activity and contribute to cancer development.

Conclusions:

  • Aberrant RTK signaling, driven by impaired negative regulation, is a critical aspect of cancer.
  • The uncoupling of RTKs from ubiquitination represents a key pathogenic process in cancer.
  • Targeting ubiquitination pathways may offer novel therapeutic strategies for cancers driven by RTK deregulation.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...